December 8, 2025BloodOpen Access

Reduced overall survival in TP53-mutated ccus is driven by prior cytotoxic exposure and cytopenia rather than leukemic progression

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Analysis shows cytotoxic exposure and cytopenia affect survival in TP53mut myeloid neoplasms, suggesting importance of clinical context.

TP53mut status did not independently predict poor outcomes in myeloid neoplasms.
Cytopenia, particularly anemia, was linked to increased mortality rates in TP53mut cases.
Observational analysis assessed survival outcomes using log-rank testing and Cox proportional hazards regression.
Findings highlight need for risk stratification that emphasizes clinical history over TP53mut presence.

Jabban et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark